Literature DB >> 24679668

Conditioned medium derived from mesenchymal stem cells culture as a intravesical therapy for cystitis interstitials.

Jan Adamowicz1, Marta Pokrywczyńska2, Tomasz Drewa3.   

Abstract

The treatment of Interstinal Cystitisis (IC) is still challenge for urologist. Available therapies do not result in long-term control of symptoms and do not provide pain relive to patients. Unique abilities of mesenchymal stem cells (MSC) could be used to develop new treatment approaches for Interstitial Cystitis. Conditioned Medium (CM) derived from MSC culture is rich in plenty of growth factors, cytokines and trophic agents which were widely reported to enhance regeneration of urinary bladder in different conditions. This ready mixture of growth factors could be used to develop intravesical therapy for patients with IC. MSC-CM has anti-apoptotic, anti-inflammatory, supportive, angiogenic, immunosuppressive and immunomodulative properties and seems to be ideal substance to prevent IC recurrence and to create favorable environment for regeneration of damaged bladder wall.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24679668     DOI: 10.1016/j.mehy.2014.02.027

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  12 in total

Review 1.  Stem Cell Therapy for Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Aram Kim; Dong-Myung Shin; Myung-Soo Choo
Journal:  Curr Urol Rep       Date:  2016-01       Impact factor: 3.092

Review 2.  Stem cells as drug delivery methods: application of stem cell secretome for regeneration.

Authors:  Christine Tran; Margot S Damaser
Journal:  Adv Drug Deliv Rev       Date:  2014-10-15       Impact factor: 15.470

Review 3.  Stem Cells in Functional Bladder Engineering.

Authors:  Jakub Smolar; Souzan Salemi; Maya Horst; Tullio Sulser; Daniel Eberli
Journal:  Transfus Med Hemother       Date:  2016-08-31       Impact factor: 3.747

Review 4.  A New Chapter for Mesenchymal Stem Cells: Decellularized Extracellular Matrices.

Authors:  Yagiz Anasiz; Riza Koksal Ozgul; Duygu Uckan-Cetinkaya
Journal:  Stem Cell Rev Rep       Date:  2017-10       Impact factor: 5.739

5.  Secretome of Differentiated PC12 Cells Restores the Monocrotophos-Induced Damages in Human Mesenchymal Stem Cells and SHSY-5Y Cells: Role of Autophagy and Mitochondrial Dynamics.

Authors:  A Srivastava; S Singh; C S Rajpurohit; P Srivastava; A Pandey; D Kumar; V K Khanna; A B Pant
Journal:  Neuromolecular Med       Date:  2018-03-30       Impact factor: 3.843

6.  Comparison of 5 Different Rat Models to Establish a Standard Animal Model for Research Into Interstitial Cystitis.

Authors:  Phil Hyun Song; So Young Chun; Jae-Wook Chung; Yeon Yong Kim; Hyo Jung Lee; Jun Nyung Lee; Yun-Sok Ha; Eun Sang Yoo; Tae Gyun Kwon; Jeongshik Kim; Dae Hwan Kim; Bum Soo Kim
Journal:  Int Neurourol J       Date:  2017-09-12       Impact factor: 2.835

7.  Personal cell therapy for interstitial cystitis with autologous stromal vascular fraction stem cells.

Authors:  Elliot B Lander; Mark H Berman; Jackie R See
Journal:  Ther Adv Urol       Date:  2019-08-17

8.  Reply to the Commentary on "New Frontiers or the Treatment of Interstitial Cystitis/Bladder Pain Syndrome-Focused on Stem Cells, Platelet-Rich Plasma, and Low-Energy Shock Wave".

Authors:  Yun-Ching Huang; Yao-Chi Chuang
Journal:  Int Neurourol J       Date:  2020-12-31       Impact factor: 2.835

9.  Animal Model of Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Whi-An Kwon
Journal:  Int Neurourol J       Date:  2018-01       Impact factor: 2.835

10.  Verification of mesenchymal stem cell injection therapy for interstitial cystitis in a rat model.

Authors:  Jae-Wook Chung; So Young Chun; Eun Hye Lee; Yun-Sok Ha; Jun Nyung Lee; Phil Hyun Song; Eun Sang Yoo; Tae Gyun Kwon; Sung Kwang Chung; Bum Soo Kim
Journal:  PLoS One       Date:  2019-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.